Fennec Pharmaceuticals (FENC) Total Liabilities (2010 - 2025)
Fennec Pharmaceuticals posted quarterly Total Liabilities of $35.1 million for Q4 2025, down 30.97% year-on-year from $50.8 million in Q4 2024, and down 34.74% on a QoQ basis from $53.8 million in Q3 2025.
Fennec Pharmaceuticals (FENC) has 16 years of Total Liabilities data on file, last reported at $35.1 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities fell 30.97% year-over-year to $35.1 million; the trailing twelve-month figure through Dec 2025 stood at $35.1 million (down 30.97% YoY), and the FY2025 full-year result was $35.1 million, down 30.97% from the prior year.
- Total Liabilities for Q4 2025 stood at $35.1 million, down from $53.8 million in the prior quarter.
- Across five years, Total Liabilities topped out at $66.2 million in Q1 2024 and bottomed at $2.9 million in Q1 2021.
- The 5-year median for Total Liabilities is $29.5 million (2022), against an average of $32.9 million.
- The widest annual swing landed in 2022, when Total Liabilities jumped 344.26%; it then plunged 30.97% in 2025.
- A 5-year view of Total Liabilities shows it stood at $6.6 million in 2021, then soared by 344.26% to $29.5 million in 2022, then soared by 30.43% to $38.5 million in 2023, then surged by 32.04% to $50.8 million in 2024, then slumped by 30.97% to $35.1 million in 2025.
- The last three Total Liabilities figures came in at $35.1 million (Q4 2025), $53.8 million (Q3 2025), and $52.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 35.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.08 Mn |
| Sep 30, 2025 | 53.75 Mn |
| Jun 30, 2025 | 52.34 Mn |
| Mar 31, 2025 | 52.28 Mn |
| Dec 31, 2024 | 50.82 Mn |
| Sep 30, 2024 | 64.09 Mn |
| Jun 30, 2024 | 64.52 Mn |
| Mar 31, 2024 | 66.18 Mn |
| Dec 31, 2023 | 38.49 Mn |
| Sep 30, 2023 | 29.56 Mn |
| Jun 30, 2023 | 29.16 Mn |
| Mar 31, 2023 | 29.16 Mn |
| Dec 31, 2022 | 29.51 Mn |
| Sep 30, 2022 | 27.62 Mn |
| Jun 30, 2022 | 7.03 Mn |
| Mar 31, 2022 | 6.63 Mn |
| Dec 31, 2021 | 6.64 Mn |
| Sep 30, 2021 | 7.00 Mn |
| Jun 30, 2021 | 5.83 Mn |
| Mar 31, 2021 | 2.89 Mn |
| Dec 31, 2020 | 2.35 Mn |
| Sep 30, 2020 | 2.89 Mn |
| Jun 30, 2020 | 3.19 Mn |
| Mar 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Sep 30, 2019 | 905,000.00 |
| Jun 30, 2019 | 1.35 Mn |
| Mar 31, 2019 | 1.45 Mn |
| Dec 31, 2018 | 1.64 Mn |
| Sep 30, 2018 | 2.08 Mn |
| Jun 30, 2018 | 847,000.00 |
| Mar 31, 2018 | 1.17 Mn |
| Dec 31, 2017 | 1.64 Mn |
| Sep 30, 2017 | 1.03 Mn |
| Jun 30, 2017 | 580,000.00 |
| Mar 31, 2017 | 427,000.00 |
| Dec 31, 2016 | 402,000.00 |
| Sep 30, 2016 | 360,000.00 |
| Jun 30, 2016 | 451,000.00 |
| Mar 31, 2016 | 345,000.00 |
| Dec 31, 2015 | 471,000.00 |
| Sep 30, 2015 | 431,000.00 |
| Jun 30, 2015 | 759,000.00 |
| Mar 31, 2015 | 1.12 Mn |
| Dec 31, 2014 | 1.76 Mn |
| Sep 30, 2014 | 3.90 Mn |
| Jun 30, 2014 | 5.71 Mn |
| Mar 31, 2014 | 5.73 Mn |
| Dec 31, 2013 | 3.21 Mn |
| Sep 30, 2013 | 4.77 Mn |
| Jun 30, 2013 | 3.46 Mn |
| Mar 31, 2013 | 11.00 Mn |
| Dec 31, 2012 | 7.32 Mn |
| Sep 30, 2012 | 1.65 Mn |
| Jun 30, 2012 | 1.56 Mn |
| Mar 31, 2012 | 2.16 Mn |
| Dec 31, 2011 | 5.47 Mn |
| Sep 30, 2011 | 9.94 Mn |
| Jun 30, 2011 | 7.51 Mn |
| Mar 31, 2011 | 283,000.00 |
| Dec 31, 2010 | 10.92 Mn |